This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB06936/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06936/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06936/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB06936/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06936
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB06936 n13:DB06936
dcterms:title
N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide
adms:identifier
n6:DB06936 n9:99443407 n10:26U n11:25113617
n3:IUPAC-Name
n4:271B6073-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6079-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6078-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6075-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6076-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6077-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6071-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B606F-363D-11E5-9242-09173F13E4C5 n4:271B6072-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6070-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B607F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6080-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B607A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B607B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B607D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B607C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B607E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6085-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6087-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6088-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6084-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6083-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6086-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6074-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6081-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6082-363D-11E5-9242-09173F13E4C5